2024 Research Articles

Related

• Italian guidelines for the management of irritable bowel syndrome in children and adolescents : Joint Consensus from the Italian Societies of: Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP), Pediatrics (SIP), Gastroenterology and Endoscopy (SIGE) and Neurogastroenterology and Motility (SINGEM)  PMID: 38486305
• Psychological distress in individuals with irritable bowel syndrome: the roles of body image and self-criticism. PMID: 38562654
  
• Characterization of the Small Bowel Microbiome Reveals Different Profiles in Human Subjects Who Are Overweight or Have Obesity  PMID: 38578969

Overview

• Small Intestinal Bacterial Overgrowth  PMID: 31536241
• Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS)  PMID: 38798120

Causes/ Risk Factors 
Diseases

• Liquid Thyroxine Improves Outcomes in Hypothyroid Patients with Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome  PMID: 38490469  PMID: 38490469

Drugs/medication 

• A multi-national survey to identify clinicians' perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis  PMID: 38430623

Surgery

• Effects of Probiotic Use on Gastrointestinal Symptoms in the Late Postoperative Period of Bariatric Surgery: A Cross-Over, Randomized, Triple-Blind, Placebo-Controlled Study  PMID: 38418752
• Prospective Monitoring of Small Intestinal Bacterial Overgrowth After Gastric Bypass: Clinical, Biological, and Gas Chromatographic Aspects  PMID: 38300481
• Blind Loop Syndrome  PMID: 36508549

​Pathophysiology

• Small intestinal microbiota: from taxonomic composition to metabolism  PMID: 38503579
• Small Intestine Bacterial Overgrowth is associated with increased Campylobacter and epithelial injury in duodenal biopsies of Bangladeshi children.    PMID: 38536881
• Fecal Coprococcus, hidden behind abdominal symptoms in patients with small intestinal bacterial overgrowth  PMID: 38796441

Associated Conditions

• Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases-Current State of Knowledge  PMID: 38790992

Children (Pediatric)

• Factors associated with D-lactic acidosis in pediatric intestinal failure: A case-control study  PMID: 38374557

Diabetes

• Small intestinal bacterial overgrowth in diabetic gastroenteropathy  PMID: 38651669  

Gastric Bypass

• Prospective Monitoring of Small Intestinal Bacterial Overgrowth After Gastric Bypass: Clinical, Biological, and Gas Chromatographic Aspects  PMID: 38300481
• Effects of Probiotic Use on Gastrointestinal Symptoms in the Late Postoperative Period of Bariatric Surgery: A Cross-Over, Randomized, Triple-Blind, Placebo-Controlled Study  PMID: 38418752

​GERD

• The Lactulose Breath Test Can Predict Refractory Gastroesophageal Reflux Disease by Measuring Bacterial Overgrowth in the Small Intestine  PMID: 38896424

H. pylori

• Helicobacter pylori infection and Parkinson's Disease: etiology, pathogenesis and levodopa bioavailability  PMID: 38166953
• Influence of Helicobacter pylori Infection and Eradication on Small Intestinal Bacterial Overgrowth and Abdominal Symptoms  PMID: 38363519

Hypothyroid

• Liquid Thyroxine Improves Outcomes in Hypothyroid Patients with Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome PMID: 38490469

IBD (Inflammatory Bowel Disease)

• The Association of Extra-oral Halitosis With Small Intestinal Bacterial Overgrowth in Inflammatory Bowel Disease  PMID: 38696141

Intestinal Failure (pediatric)

• Factors associated with D-lactic acidosis in pediatric intestinal failure: A case-control study  PMID: 38374557

Liver Disease

• Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study  PMID: 38337613
• Dysbiosis and nutrition in steatotic liver disease: addressing the unrecognized small intestinal bacterial overgrowth (SIBO) challenge  PMID: 38499938
• Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study  PMID: 38854668
• Impact of small intestinal bacterial overgrowth on systemic inflammation, circulatory and renal function, and liver fibrosis in patients with cirrhosis and ascites  PMID: 38779647
• MASLD can cause halitosis by small intestinal bacterial overgrowth  PMID: 38764349

Parkinson’s

• Helicobacter pylori infection and Parkinson's Disease: etiology, pathogenesis and levodopa bioavailability  PMID: 38166953
• A review of the gastrointestinal, olfactory, and skin abnormalities in patients with Parkinson's disease  PMID: 38195133
• Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease  PMID: 38729797
• The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications  PMID: 38570412

Systemic Sclerosis

• [Severe small bowel involvement and chronic intestinal pseudo-obstruction in systemic sclerosis (scleroderma): Pathophysiological, diagnostic and therapeutic basis, including parenteral nutrition]  PMID: 38388303
• Diffuse Gastrointestinal Motor Compromise in Patients with Scleroderma: Utility of Minimally Invasive Techniques  PMID: 37982941
• A multi-national survey to identify clinicians' perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis  PMID: 38430623

Testing

• Gastric, small bowel and colonic motility and breath-testing  /doi.10.1016/j.mpmed.2024.01.004​
• Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS)  PMID: 38798120
• Small Intestinal Bacterial Overgrowth (SIBO), a clinically overdiagnosed entity?  PMID: 38719183
• Glucose breath test for the detection of small intestine bacterial overgrowth: Impact of diet prior to the test  PMID: 38606691
• Capsules for the Diagnosis and Treatment of Gastrointestinal Motility Disorders- A Game Changer  PMID: 38630422
  

Methane

• The Lactulose Breath Test Can Predict Refractory Gastroesophageal Reflux Disease by Measuring Bacterial Overgrowth in the Small Intestine  PMID: 38896424

Thyroid

• Evaluation of the therapeutic efficacy of different doses of LT4 in pregnant women with high-normal TSH levels and TPOAb positivity in the first half of pregnancy  PMID: 38600581

​Treatment 

• Common questions and rationale answers about the intestinal bacterial overgrowth syndrome (SIBO)  PMID: 38852778
• The importance of food quality, gut motility, and microbiome in SIBO development and treatment  PMID: 38657418

Antibiotics

• Antibiotics for Dyspepsia: Hp, SIBO, IMO, or Something Else?  PMID: 38363520
• Symptomatic Response to Antibiotics in Patients With Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-analysis  PMID: 38173154

Herbal Antibiotics

• Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial  PMID: 38613116

Diet

• Food Intolerances, Food Allergies and IBS: Lights and Shadows  PMID: 38257158
• The Role of Diet in the Management of Irritable Bowel Syndrome: A Comprehensive Review  PMID: 38496157

Probiotics

• Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial  PMID: 38613116
• Effects of Probiotic Use on Gastrointestinal Symptoms in the Late Postoperative Period of Bariatric Surgery: A Cross-Over, Randomized, Triple-Blind, Placebo-Controlled Study  PMID: 38418752
• Probiotics and Prebiotics in Subclinical Hypothyroidism of Pregnancy with Small Intestinal Bacterial Overgrowth  PMID: 37032411

Prokinetics

• Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study  PMID: 38337613
• Clinical outcomes before and after prucalopride treatment: an observational study in patients with chronic idiopathic constipation in the USA  PMID: 38357940
• Safety and Effectiveness of Prucalopride in Children with Functional Constipation with and without Upper Symptoms  PMID: 38175354
• Effect of Iberogast (STW5) on tolerance to colonic gas in patients with irritable bowel syndrome: A randomized, double-blind, placebo control clinical trial  PMID: 38361151
• 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy  PMID: 38638303

Rifaximin

• Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs  PMID: 38366822
• Effect of Trimebutine and Rifaximin on Breath Hydrogen and Methane by Glucose Breath Test in Patients With Functional Bloating: A Randomized Double-blind Clinical Trial  PMID: 38576371

Trimebutine Maleate

• Effect of Trimebutine and Rifaximin on Breath Hydrogen and Methane by Glucose Breath Test in Patients With Functional Bloating: A Randomized Double-blind Clinical Trial  PMID: 38576371  

Diet: FODMAP Diet

• The Role of the FODMAP Diet in IBS  PMID: 38337655
• Alterations in gut microbiota caused by major depressive disorder or a low FODMAP diet and where they overlap  PMID: 38260072
• Can we predict who will respond to a low-FODMAP diet in irritable bowel syndrome?  PMID: 38238032
• Nutrition and Disorders of Gut-Brain Interaction  PMID: 38202005
• Effect of fibre fortification of low FODMAP pasta  PMID: 38225882
• Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome  PMID: 38401741
• Fructan Concentrations in Cooked Cereal Grains as a Nutritional Consideration for Low-FODMAP Diet  PMID: 38257195
• Quality characteristics of cereal-based foods enriched with different degree of polymerization inulin: A review  PMID: 38431396
• Diet low in fodmaps: fundamentals, evidence and controversies  PMID: 38493009
• Exploration of differential responses to FODMAPs and gluten in people with irritable bowel syndrome- a double-blind randomized cross-over challenge study  PMID: 38347192
• Fructose malabsorption and fructan malabsorption are associated in patients with irritable bowel syndrome  PMID: 38654193
• Effect of the Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet on Control of Pediatric Irritable Bowel Syndrome and Quality of Life Among a Sample of Egyptian Children: A Randomized Controlled Clinical Trial.  PMID: 38910620
• The low-FODMAP diet PMID: 38906802
• Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis.  PMID: 38892659  
• Is the Mediterranean Low Fodmap Diet Effective in Managing Irritable Bowel Syndrome Symptoms and Gut Microbiota? An Innovative Research Protocol.  PMID: 38892525
• A diet low in fermentable oligo-, di-, monosaccharides and polyols improves abdominal and overall symptoms in persons with all subtypes of irritable bowel syndrome.  PMID: 38887150  
• Unveiling the dynamics of gut microbial interactions: a review of dietary impact and precision nutrition in gastrointestinal health.  PMID: 38873568 
• [Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet].  PMID: 38809220
• Causative Factors, Clinical Manifestations, and Therapeutic Strategies for Irritable Bowel Syndrome.  PMID: 38779277
• Evolution, adaptation, and new applications of the FODMAP diet.  PMID: 38770353
• The efficacy and real-world effectiveness of a diet low in fermentable oligo-, di-, monosaccharides and polyols in irritable bowel syndrome: A systematic review and meta-analysis.  PMID: 38754307  
• Global research trend and hotspot in the low FODMAP diet: a bibliometric analysis.  PMID: 38741213
• Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results from a Double-Blind, Pilot Randomized Controlled Trial.  PMID: 38729393
• All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel Syndrome.  PMID: 38729390
• A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome.  PMID: 38717025
• Effects of a low FODMAP diet on the symptom management of patients with irritable bowel syndrome: a systematic umbrella review with the meta-analysis of clinical trials.  PMID: 38711328
• Nutritional safety and status following a 12-week strict low FODMAP diet in patients with irritable bowel syndrome.  PMID: 38689453
• Coffee, Alcohol, and Artificial Sweeteners Have Temporal Associations with Gastrointestinal Symptoms.  PMID: 38662159
• Production, modification and degradation of fructans and fructooligosacharides by enzymes originated from plants.  PMID: 38649077
• Managing irritable bowel syndrome: balancing diet and pharmacotherapy.  PMID: 38643783
• A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.  PMID: 38643782
• Efficacy of a Low-FODMAP Diet for Coeliac Patients with Persistent IBS-like Symptoms despite a Gluten-Free Diet: A Systematic Review.  PMID: 38613127